157 related articles for article (PubMed ID: 24807324)
1. Oophorectomy and hysterectomy and cancer incidence in the Cancer Prevention Study-II Nutrition Cohort.
Gaudet MM; Gapstur SM; Sun J; Teras LR; Campbell PT; Patel AV
Obstet Gynecol; 2014 Jun; 123(6):1247-1255. PubMed ID: 24807324
[TBL] [Abstract][Full Text] [Related]
2. Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review.
Evans EC; Matteson KA; Orejuela FJ; Alperin M; Balk EM; El-Nashar S; Gleason JL; Grimes C; Jeppson P; Mathews C; Wheeler TL; Murphy M;
Obstet Gynecol; 2016 Sep; 128(3):476-85. PubMed ID: 27500347
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomy.
Cusimano MC; Ferguson SE; Moineddin R; Chiu M; Aktar S; Liu N; Baxter NN
Am J Obstet Gynecol; 2022 Feb; 226(2):220.e1-220.e26. PubMed ID: 34563499
[TBL] [Abstract][Full Text] [Related]
4. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.
Obermair A; Youlden DR; Baade PD; Janda M
Int J Cancer; 2014 May; 134(9):2211-22. PubMed ID: 24127248
[TBL] [Abstract][Full Text] [Related]
5. Hysterectomy and Risk of Breast, Colorectal, Thyroid, and Kidney Cancer - an Australian Data Linkage Study.
Wilson LF; Tuesley KM; Webb PM; Dixon-Suen SC; Stewart LM; Jordan SJ
Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):904-911. PubMed ID: 33619026
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
Schmeler KM; Sun CC; Bodurka DC; White KG; Soliman PT; Uyei AR; Erlichman JL; Arun BK; Daniels MS; Rimes SA; Peterson SK; Slomovitz BM; Milam MR; Gershenson DM; Lu KH
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):515-20. PubMed ID: 16946209
[TBL] [Abstract][Full Text] [Related]
7. Concurrent risk-reduction surgery in patients with increased lifetime risk for breast and ovarian cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database.
Elmi M; Azin A; Elnahas A; McCready DR; Cil TD
Breast Cancer Res Treat; 2018 Aug; 171(1):217-223. PubMed ID: 29761322
[TBL] [Abstract][Full Text] [Related]
8. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies.
Rice MS; Hankinson SE; Tworoger SS
Fertil Steril; 2014 Jul; 102(1):192-198.e3. PubMed ID: 24825424
[TBL] [Abstract][Full Text] [Related]
9. Concurrent uterine surgery and uptake of hormone therapy in patients undergoing bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications.
Sasse SA; Lee SS; Rajeev P; Sharma SR; Kahan T; Pothuri B
Gynecol Oncol; 2023 Dec; 179():131-137. PubMed ID: 37988946
[TBL] [Abstract][Full Text] [Related]
10. Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study.
Obermair A; Youlden D; Baade P; Janda M
Asia Pac J Clin Oncol; 2017 Feb; 13(1):68-78. PubMed ID: 27230709
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
Schmeler KM; Lynch HT; Chen LM; Munsell MF; Soliman PT; Clark MB; Daniels MS; White KG; Boyd-Rogers SG; Conrad PG; Yang KY; Rubin MM; Sun CC; Slomovitz BM; Gershenson DM; Lu KH
N Engl J Med; 2006 Jan; 354(3):261-9. PubMed ID: 16421367
[TBL] [Abstract][Full Text] [Related]
13. Hysterectomy, Oophorectomy, and Risk of Thyroid Cancer.
Luo J; Hendryx M; Manson JE; Liang X; Margolis KL
J Clin Endocrinol Metab; 2016 Oct; 101(10):3812-3819. PubMed ID: 27459531
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer rates after hysterectomy with and without salpingo-oophorectomy.
Chan JK; Urban R; Capra AM; Jacoby V; Osann K; Whittemore A; Habel LA
Obstet Gynecol; 2014 Jan; 123(1):65-72. PubMed ID: 24463665
[TBL] [Abstract][Full Text] [Related]
15. National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998-2011.
Mikhail E; Salemi JL; Mogos MF; Hart S; Salihu HM; Imudia AN
Am J Obstet Gynecol; 2015 Nov; 213(5):713.e1-13. PubMed ID: 25935772
[TBL] [Abstract][Full Text] [Related]
16. Hysterectomy and Bilateral Salpingo-Oophorectomy: Variations by History of Military Service and Birth Cohort.
Callegari LS; Gray KE; Zephyrin LC; Harrington LB; Gerber MR; Cochrane BB; Weitlauf JC; Bean-Mayberry B; Bastian LA; Mattocks KM; Haskell SG; Katon JG
Gerontologist; 2016 Feb; 56 Suppl 1(Suppl 1):S67-77. PubMed ID: 26768393
[TBL] [Abstract][Full Text] [Related]
17. Risk of Diabetes After Hysterectomy With or Without Oophorectomy in Postmenopausal Women.
Luo J; Manson JE; Urrutia RP; Hendryx M; LeBlanc ES; Margolis KL
Am J Epidemiol; 2017 May; 185(9):777-785. PubMed ID: 28338878
[TBL] [Abstract][Full Text] [Related]
18. Bilateral oophorectomy and risk of cancer in African American women.
Boggs DA; Palmer JR; Rosenberg L
Cancer Causes Control; 2014 Apr; 25(4):507-13. PubMed ID: 24487726
[TBL] [Abstract][Full Text] [Related]
19. Long-term cancer risk after hysterectomy on benign indications: Population-based cohort study.
Altman D; Yin L; Falconer H
Int J Cancer; 2016 Jun; 138(11):2631-8. PubMed ID: 26800386
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Health Consequences After Ovarian Removal at Benign Hysterectomy : A Nationwide Cohort Study.
Gottschau M; Rosthøj S; Settnes A; Aalborg GL; Viuff JH; Munk C; Jensen A; Kjær SK; Mellemkjær L
Ann Intern Med; 2023 May; 176(5):596-604. PubMed ID: 37068275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
